Who owns Evelo Biosciences Inc?

Tip: Access positions for across all investors

Analyze quarterly positions in Evelo Biosciences with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Evelo Biosciences stock

Who bought or sold Evelo Biosciences Inc this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of
FMR 8.0M $86M 18% Mar 2021
HarbourVest Partners 3.1M $33M 0% Mar 2021
Credit Suisse 3.0M $33M 10% Mar 2021
BlackRock 1.6M $18M 25% Mar 2021
Vanguard Group 1.4M $15M 17% Mar 2021
Artal Group 1.0M $11M 43% Mar 2021
State Treasurer State Of Michigan 900k $9.6M 100% Mar 2021
Avidity Partners Management 800k $8.6M 100% Mar 2021
Mayo Clinic 479k $5.1M -1% Mar 2021
Geode Capital Management 386k $4.1M 18% Mar 2021
State Street Corporation 322k $3.4M 9% Mar 2021

Setup an alert

Want to be notified whenever an investor makes a significant change to their holdings of Evelo Biosciences?

Northern Trust 255k $2.7M 12% Mar 2021
Charles Schwab Investment Management 170k $1.8M 29% Mar 2021
Invesco 165k $1.8M 20% Mar 2021
Marshall Wace 150k $1.6M 262% Mar 2021
Two Sigma Investments 138k $1.5M 100% Mar 2021
Trustees of Columbia University in the City of New York 114k $1.2M 0% Mar 2021
Caas Capital Management 83k $883k 100% Mar 2021
Federated Investors 70k $754k 260819% Mar 2021
Jpmorgan Chase & Co 68k $726k 30% Mar 2021
Nuveen Asset Management 67k $712k 19% Mar 2021
Two Sigma Advisers 66k $708k 100% Mar 2021
Bank of New York Mellon 56k $597k -5% Mar 2021
Wells Fargo & Company 50k $535k 19% Mar 2021
Susquehanna International 50k $534k 100% Mar 2021
AQR Capital Management 48k $510k 100% Mar 2021
Citadel Advisors 36k $382k 57% Mar 2021
California State Teachers Retirement System 35k $372k 15% Mar 2021
Bank of America Corporation 33k $350k 367% Mar 2021
Larson Financial Group 31k $334k 10% Mar 2021
Vontobel Holding 31k $333k 100% Mar 2021
Parametric Portfolio Associates 28k $302k 126% Mar 2021
New York State Common Retirement Fund 20k $218k 89% Mar 2021
Rhumbline Advisers 20k $210k 1% Mar 2021
Barclays 19k $206k 198% Mar 2021
Deutsche Bank Aktiengesellschaft 17k $183k 3% Mar 2021
Goldman Sachs Group 14k $150k 25% Mar 2021
Manufacturers Life Insurance Company 14k $149k -2% Mar 2021
American International 13k $144k 15% Mar 2021
Jane Street 13k $134k -28% Mar 2021
Alliancebernstein 11k $119k -13% Mar 2021
UBS Group 3.5k $38k -20% Mar 2021
Dorsey Wright & Associates 3.2k $34k 100% Mar 2021
Bnp Paribas Arbitrage, Snc 2.6k $28k -34% Mar 2021
Meeder Asset Management 2.6k $0 100% Mar 2021
Legal & General Group 2.5k $27k 11% Mar 2021
Banque Cantonale Vaudoise 2.5k $27k 0% Mar 2021
Bank Of Montreal 2.4k $24k -48% Mar 2021
Tower Research Capital 1.9k $21k -44% Mar 2021
Summit Investment Advisors 1.7k $18k 49% Mar 2021
Royal Bank of Canada 1.7k $18k 56% Mar 2021
Citigroup 1.5k $16k -58% Mar 2021
Sandy Spring Bank 465.00 $5.0k -70% Mar 2021
Simplex Trading 215.00 $1.999500 100% Mar 2021

Who sold out of Evelo Biosciences?

Fund or Company Name Date Sold Shares Held Valued At
Morgan Stanley Dec 2020 92k $1.1M
Hsbc Holdings Dec 2020 12k $145k
Peddock Capital Advisors Dec 2020 3.7k $44k